摘要
目的:通过对60例阴虚体质黄褐斑患者随机采用“中药内服祛斑汤结合调周法”和外用“白面散”或者“中药内服祛斑汤”和外用“白面散”,观察研究调周法的疗效及其对于阴虚体质病人向平和体质转化的趋势。
方法:选择女性黄褐斑患者60例,随机分为治疗组(30例)和对照组(30例)。治疗组内服祛斑汤结合调周法和外用白面散,对照组内服祛斑汤和外用白面散,12周后对其疗效进行比较。
结果:经过12周的治疗,黄褐斑疗效为治疗组基本治愈6例,显效15例,总有效率86.7%;对照组基本治愈2例,显效4例,总有效率60%,两组比较差异有显著性(P<0.05)。经过12周的治疗,病人体质有向平和质转化的趋势,治疗组总有效率为68.93%;对照组总有效率为56.67%。两组总有效率比较差异有显著性(P<0.05)。
结论:调周法应用于阴虚质黄褐斑有很好的临床疗效,在治疗过程中能够使阴虚病人的体质出现转化成平和体质的趋势,该方法简单、使用方便,易于推广
Objective:60 cases of chloasma were randomly Yin constitution a "Soup with Chinese Herbs freckle tone Week Law" and the topical "White-powder" or "Chinese Herbs freckle soup" and the topical "flour powder, " observational studies adjusted week efficacy of the law and the constitution for yin calm and physical transformation of the patient to the trend.
Methods: 60 patients with chloasma women were randomly divided into treatment group (30 cases) and control group (30 cases). Oral combined treatment group was adjusted weeks freckle Tang law and topical flour scattered in the control group Oral freckle soup and external flour powder, 12 weeks after its effects were compared.
Results: After 12 weeks of treatment, the treatment group were cured in 6 cases,15 cases were a total effective rate was 86.7%; control group,2 patients were cured, markedly effective in 4 cases, total effective rate of 60%, the difference was significant (P<0.05). After 12 weeks of treatment, patients have to moderate physical transformation of the trend of quality, total effective rate was 68.93%; control group, the total effective rate was 56.67%, the difference was significant (P<0.05).
引文
[1]张学军.皮肤性病学(第6版).北京:人民卫生出版社,2005
[2]王琦.中医体质学,2009;2
[3]中国中西医结合学会皮肤性病专业委员会色素病学组制定的《黄褐斑的临床诊断及疗效标准》和中国中医药出版社编撰的《中医美容学》确定。
[4]王琦.中医体质学,2009;2
[5]孔庆晅,王莉.黄褐斑发病机制与中医治疗浅析.中国中西医结合皮肤性病学杂志2007年第6卷第2期
[6]王琦.中医体质学2008.人民卫生出版社
[7]沈金鏊.杂病源流犀浊,北京:中国中医药出版社,1996,第一版:372~373.
[8]陈士铎.辨证录,北京:中国中医药出版社,2001,第一版:753.
[9]孙思邈.备急千金要方,北京:中医古籍出版社,1999,第一版:189.
[10]李时珍.本草纲目,北京:中国中医药出版社,1998,第一版,121.
[11]方隅.医林绳墨,北京:商务印书馆出版,1957,第一版,75.
[12]薛己.内科摘要,北京:中国中医药出版社,1997,第一版,177.
[13]吴昆.医方考,南京:江苏科学技术出版社,1985,第一版:335.
[14]郑寿全.医法圆通,北京:中国中医药出版社,1993,第一版:22.
[15]郑寿金.医理真传,北京:中国中医药出版社,1993,第一版:101.
[16]姚止庵.素问经注节解,北京:人民卫生出版社,1963,第一版:256.
[17]张琦.素问释义,北京:科学技术出版社,1998,第一版:153.
[18]李顺保.温病学全书(上册),北京:学苑出版社,1999,第一版:121.
[19]吴又可.瘟疫论,北京:中医古籍出版社,2004,第一版:2.
[20]吴又可.瘟疫论,北京:中医古籍出版社,2004,第一版:314.
[21]吴又可.瘟疫论,北京:中医古籍出版社,2004,第一版:321.
[22]苏树蓉,钟柏林.黎欣.1061例小儿体质调查及体质分型的研究.中医杂志,
[23]王琦.中医体质学,2009;2
[24]《中医美容学》中国中医药出版社158页
[25]王琦.中医体质学,2009;2
[26]邓燕,杨柳.中药对黑色素细胞及酪氨酸酶调节作用的研究进展.新中医,2003,35 (5) :72
[27]邓燕,杨柳.不同浓度的中药刺蒺藜对黑色素细胞和酪氨酸酶的作用.第一军医大学学报,2002,22(11):1017-12
[1]冯安吉.黄褐斑病因及发病机理[J].第一军医大学学报,2000,20(2):183~184
[2]张晓刚.张学文教授治疗黄褐斑经验[J].新中医,2002,34(1):11
[3]胡文科.桂枝败酱美容汤治疗黄褐斑186例[J].四川中医,1999,17(7):43
[4]朱启芳.辨证治疗面部黄褐斑30例[J].辽宁中医杂志,2001,28(11):678
[5]王邦才.从肝论治面部黄褐斑[J].中国中医药信息杂志,2000,7(14):69
[6]张克忠.祛斑饮治疗黄褐斑44例[J].江苏中医,2000,21(1):24
[7]王晓华.活血化瘀法治疗黄褐斑35例[J].吉林中医药,2003,23(3):30~31
[8]郑乐,刘嘉茵,孙勇,等.黄褐斑女性激素的关系[J].中华皮肤科杂志,1996,29(3):297
[9]Vazquez M, HeorM, Bermaman C, et al.Malasma inmen:a clin-ical and histologic stixly[J]. Int Dermatal,1988,27:25
[10]Pere Zm, Sanchez, AhuiloF. Endocrinologic proflile of patiertswith idopathic melasma[J]. J Invest Dermatol,1983,81:543
[11]万苗坚,蔡瑞康,张其亮,等.男性黄褐斑皮损区微生态及血清性激素水平的研究[J].中华医学美容杂志,1999,5(2):32~36
[12]祝小枫,盛志勇.黄褐斑生态治疗和菌群改变的研究[J].中国皮肤性病学杂志,1995,9(2):70~71
[13]万苗坚,赵广,蔡瑞康,等.黄褐斑患者皮损区微生态改变的探讨[J].临床皮肤科杂志,1998,26(2):87~89
[14]小仓良平.紫外线照射の皮肤疾患[J].最新医学,1978,33:686~690
[15]陈瑷,周玫.自由基学[M].北京:人民军医出版社,1999.42~46
[16]Hai CX. Studies of lipid peroxidation of people living in high Se-lenium area[J]. China Environmental Science,1993,4(1):8-50
[17]Grimes PE. Melasma, etiologic and therapeutic considerations. Arch Dermatol 1995:13(12):1453
[18]万苗坚·黄褐斑研究进展·国外医学皮肤性病学分册1996;22(4):209
[19]Boloonia J.Murray M, Pawelck J, et al. UVB-induced melano-genesis may be mediated through the MSH-receptor system. J In-vest Dermatol 1989;92 (5):651
[20]Kadono S, Manaka I, kawashimaM, et al. The role of the epider-mal endothlin cascade in the hyperpigmentation mechanism of lengigo sennilis. J Invest Dermatol 2001;116(4):571
[21]万屏,梁国华,付雷,等·孕期及非孕期黄褐斑患者几种微量元素对比观察·中国皮肤性病学杂志1998:12(5):273
[22]梁存让,徐汉卿,沈纪文,等·黄褐斑发病机理及活血化瘀法治疗的探讨·临床皮肤科杂志1985;14(5):238
[23]陈燕明,秦茂林,肖利,等·黄褐斑的血液流变学·临床皮肤科杂志 1992;21(2):95
[24]林新瑜,周光平,李利,等·女性黄褐斑患者的血清酶学及血液流变学初步分析·临床皮肤杂志1997:26(6):359
[25]张素洁,中医辨证分析治疗黄褐斑与血液流学关系的研究与分析·中国中医基础学杂志1998:4(11):35
[26]Javaheri SM, Handa S,Kaur I, et al. Safety and efficacy of gly-colic acid facial peel in Indianwomenwithmelasma. Int J Der-matol 2001;40(5):354
[27]Kauh YC, Zachian TF. Melasma. Adv Exp Med Biol 1999;25(3):491
[28]柴雁·逍遥散加味治疗黄褐斑60例[J]·安徽医学·1997·18(5):57·
[29]龙家俊·消斑汤治疗黄褐斑105例[J]·湖南中医药杂志·1998·14(1):57·
[30]何文扬·丹栀逍遥散治疗面部黄褐斑82例[J]·中医药信息·1999·16(5):30·
[31]张青山。一贯煎治疗面部黄褐斑50例[J]·浙江中医药·2000·35(2):53·
[32]谭为民·中药化斑口服液治疗黄褐斑临床疗效观察[J]·岭南皮肤性病科杂志·2001·8(2):94·
[33]杨慧兰·祛斑增白散治疗黄褐斑疗效观察及临床分析[J]·实用医学杂志·1995·11(8):544-545·
[34]张惠·归白药膜治疗68例黄褐斑疗效观察[J]·皮肤病与性病·2000·22(4):25-26·
[35]杨军·五妙水仙膏治疗黄褐斑及寻常性痤疮35例[J]·陕西中医·2001·22(3):157·
[36]黄真·斑克霜治疗黄褐斑的实验和临床研究[J]·浙江中医杂志·1996·31(9):429·
[37]李远实·梅花针叩刺加拔罐治疗黄褐斑59例[J]·中国针灸·1998·18(2):110·
[38]朱志·耳穴割刺加耳压治疗黄褐斑32例[J]·云南中医中药杂志·1998·19(1):37·
[39]朱鸿铭.菟丝祛斑汤治疗面部黄褐斑53例,山东医药,1980;(1):42
[40]韩元.中药治疗黄褐斑.临床皮肤科杂志,1981;(4):194
[41]刘远坝.七草汤治疗黄褐斑110例.陕西中医,1990;11(2):65
[42]官鹏声.美肤冲剂临床疗效观察.云南中医学院学报,1994;17(1):3~5
[43]池晓玲.六白化斑汤治疗黄褐斑100例.中国医学美学美容杂志,1994;3(4):210
[44]吴锦发.补肾为主治疗黄褐斑.四川中医,1994;(3):46
[45]肖国良.大黄虫丸治疗重症黄褐斑一得.中医药学报,1994;(1):52
[46]黄吉时.秦皇祛斑茶治疗黄褐斑.新中医,1994;26(10):45
[47]Kauh YG, Zachian TF. Melasma[A]. In:Mallia C. Uitto J, Rheumaderm[M]. NewYork:Kluwer Academic/Plenum,1999.491-499.
[48]Palumh A, Dischia M, Misuraca G. Mechznism of inhibition of melanogenesis byhydroquinone[J]. Biochem Biophys Acta,1991,1073:85-90.
[49]Salopek TG, Jimbow K. New treatment op-tions for the patient with facial hyperpig-mentation[J]. Curr Opin Dermatol,1995,61-68.
[50]Verallo-Rowell VM, Verallo V, Graupe K, et al. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma [J]. Acta Derm Venereol Suppl,1989,143:58-61.
[51]Balina LM, Graupe K. The treament of melasma:20% azelaic acid versus 4% hy-droquinone cream[J].Int J Dermatol,1991,30:893-895.
[52]Bahawan J. Short-and long-term histologic effects of topical tretinoin on photodamaged skin[J].Int J Dermatol,1998,37:286-292.
[53]Bulengo-Ransby SM, Griffiths CE, Kim-brough-Green CK,et al. Topical tretinoin(retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients[J]. N Engl J Med,1993, 328:1438-1443.
[54]Orlow SJ, Dhakraborth AK, Pawelek JM. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster mi-lanoma cell lines [J]. J Invest Dermatol,1990,94:461-464.
[55]Mishima Y, Hatta S, Ohyama Y, et al. In-duction of melanogenesis suppression: celluar pharmacology and mode of differential action [J]. Pigment Cell Res,1988,1:367-374.
[56]Kahn V. Effect of kojic acid on the oxida-tion of Dl-DOPA, norepinephine, and dopamine by mushroom tyrosinase[J]. Pig-ment Cell Res,1995,8:234-240.
[57]Jimbow K. N-acety-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with malasma[J]. Arch Dermatol,1991,127:1528-1534.
[58]Thomas PD, Kishi H, Cao H. Selective in-corporation and specific cytocidal effect as thcellular basis for the antimelanoma action in sulphur containing tyrosine analogs[J]. J In-vest Dermatol,1999,113:928-934.
[59]Minamitsuji Y, Toyofuku K, Sugiyama S, et al. Sulphur containing tyrosine analogs can cause selective melanocytotoxicity in-volving tyrosinase-mediated apoptosis[J]. Chin J Derm Venereol, Sep.2004, Vol.18, No.9 J Invest Dermatol,1999,4:130-136.
[60]Ellis DAF, Tan AKW. How we do it:management of facial hyperpigmentation[J]. J Otolaryngol,1997,26:286-289.